Table 3.
Comparison of patients in relation to 1-year mortality
| Characteristics | 1-year mortality | p value | |
|---|---|---|---|
| Yes (n = 106) | No (n = 227) | ||
| Age (years) | 58.2 ± 17.3 | 58.9 ± 14.5 | 0.928 |
| Male gender | 63 (59.4) | 150 (66.1) | 0.239 |
| Etiology: | |||
| Ischemic | 27 (25.5) | 67 (29.5) | 0.445 |
| Non-ischemic (non-chagasic) | 44 (41.5) | 119 (52.4) | 0.063 |
| Chagasic | 35 (33.0) | 41 (18.1) | 0.002 |
| LVEF (%) | 28.9 ± 9.5 | 27.6 ± 12.1 | 0.116 |
| Hemoglobin (g/L) | 13.3 ± 2.2 | 13.1 ± 1.8 | 0.311 |
| Hemoglobin (g/L) | 80.8 ± 42.8 | 71.8 ± 42.1 | 0.016 |
| Creatinine (mg/dL) | 1.5 ± 0.5 | 1.5 ± 0.8 | 0.043 |
| Sodium (mEq/L) | 135.3 ± 4.9 | 137.1 ± 4.8 | 0.001 |
| SBP (mmHg) | 103.1 ± 20.7 | 106.4 ± 24.5 | 0.505 |
| DBP (mmHg) | 69.3 ± 15.3 | 68.4 ± 19.3 | 0.503 |
| Medications | |||
| Inotropic agents | 75 (71.4) | 127 (57.5) | 0.015 |
| ACEI | 69 (65.1) | 172 (75.8) | 0.042 |
| Beta-blocker | 36 (34.0) | 163 (71.8) | < 0.001 |
| Losartan | 12 (11.3) | 30 (13.2) | 0.649 |
| Nitrates | 47 (44.3) | 70 (30.8) | 0.014 |
| Hydralazine | 38 (35.8) | 70 (30.8) | 0.333 |
| Digoxin | 76 (71.7) | 118 (52.0) | < 0.001 |
| Spironolactone | 11 (10.4) | 37 (16.3) | 0.161 |
| Furosemide | 90 (84.9) | 171 (75.3) | 0.032 |
| Hydrochlorothiazide | 18 (17.0) | 41 (18.1) | 0.839 |
Data are expressed as mean ± standard deviation or number (percentage). LVEF: left ventricular ejection fraction; SBP: systolic blood pressure; DBP: diastolic blood pressure; ACEI: angiotensin-converting enzyme inhibitor.